Benjamin Edwards Inc. Sells 3,987 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Benjamin Edwards Inc. trimmed its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 27.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,379 shares of the company’s stock after selling 3,987 shares during the quarter. Benjamin Edwards Inc.’s holdings in Privia Health Group were worth $203,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. First Horizon Advisors Inc. raised its position in shares of Privia Health Group by 53.8% during the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Privia Health Group by 7,833.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after acquiring an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group during the fourth quarter worth about $51,000. Quadrant Capital Group LLC raised its position in shares of Privia Health Group by 11.8% during the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company’s stock worth $98,000 after acquiring an additional 3,249 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $25.02 on Monday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.09. The business’s fifty day moving average price is $23.38 and its 200-day moving average price is $22.34. The stock has a market capitalization of $3.04 billion, a PE ratio of 250.23, a P/E/G ratio of 3.47 and a beta of 0.87.

Insider Activity

In other news, CEO Parth Mehrotra sold 15,100 shares of the company’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total transaction of $352,283.00. Following the transaction, the chief executive officer now owns 454,281 shares of the company’s stock, valued at $10,598,375.73. This represents a 3.22% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David Mountcastle sold 5,630 shares of the company’s stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. This represents a 3.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,484 shares of company stock valued at $799,163 in the last 90 days. Insiders own 10.70% of the company’s stock.

Wall Street Analysts Forecast Growth

PRVA has been the subject of a number of research analyst reports. Canaccord Genuity Group lifted their target price on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. Barclays lifted their target price on Privia Health Group from $21.00 to $23.00 and gave the stock an “equal weight” rating in a report on Thursday, April 10th. Robert W. Baird lifted their target price on Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a report on Tuesday, April 15th. Needham & Company LLC reiterated a “buy” rating and issued a $30.00 target price on shares of Privia Health Group in a report on Thursday, April 10th. Finally, Piper Sandler lifted their target price on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $27.38.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.